SCHEMBL25254065

SCHEMBL25254065

Cn1c(-c2ccc(N)cc2F)cccc1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRPF1 P55201 2/20 0.41
▸ BRD4 O60885 3/20 0.40
▸ ANPEP P15144 2/20 0.38
▸ DPP4 P27487 1/20 0.38
▸ NPC1 O15118 3/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ TSHR P16473 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ LMNA P02545 2/20 0.36
▸ GAA P10253 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ PIK3CA P42336 1/20 0.36
▸ PIK3CB P42338 1/20 0.36
▸ PIK3CG P48736 1/20 0.36
▸ AR P10275 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30230953 0.76 BRPF1 (0.46) BRPF1BRD4ANPEPDPP4NPC1
SCHEMBL30230784 0.75 CYP3A4 (0.41) BRD4ALDH1A1SMN1; SMN2CYP3A4MAPT
SCHEMBL29710146 0.72 ABL1 (0.39) BRPF1BRD4NPC1ALDH1A1RAB9A
SCHEMBL23165769 0.72 ABL1 (0.39) BRPF1BRD4NPC1ALDH1A1RAB9A
SCHEMBL712310 0.69 TSHR (0.48) NPC1ALDH1A1RAB9ASMN1; SMN2TSHR
SCHEMBL31148268 0.68 ALDH1A1 (0.42) BRD4ALDH1A1MAPTPIK3CAPIK3CB
SCHEMBL29349036 0.68 ALDH1A1 (0.46) BRPF1BRD4NPC1ALDH1A1RAB9A
SCHEMBL25257971 0.68 BRD4 (0.46) BRPF1BRD4ANPEPDPP4NPC1
SCHEMBL25258821 0.68 BRD4 (0.38) BRPF1BRD4TP53MAPTPIK3CA
SCHEMBL19390809 0.67 AR (0.54) ANPEPDPP4ALDH1A1MAPTAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116547275-A IL-17A modulators 赛诺菲 2023-08-04 — — CN disclosed
US-20230227427-A1 IL-17A MODULATORS SANOFI (FR) 2023-07-20 — — US disclosed
EP-4157827-A1 IL-17A MODULATORS SANOFI (FR) 2023-04-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227427-A1 IL-17A MODULATORS IL17A, IL2, IL15 BRPF1 3370/4885BRD4 1372/4885ANPEP 3447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback